Literature DB >> 6749057

Influence of local-regional lymph node metastases on prognosis in neuroblastoma.

E M Rosen, J R Cassady, C Kretschmar, C N Frantz, R Levey, S E Sallan.   

Abstract

Data relative to the prognostic and therapeutic significance of lymph node metastases in regionally confined neuroblastoma (Evans stages II-III) are scant. We have analyzed lymph node status in order to assess the significance of nodal involvement. Disease-free survival (minimum follow-up of 2 years) was 84% (21/25) among node-positive patients compared with 95% (18/19) for node-negative patients (P greater than 0.1, two-tailed test). These results contrast with the results from two other centers in which lymph node involvement was a significant adverse prognostic indicator. The use of intensive multimodal therapy including surgical resection of the primary tumor, wide-field radiation therapy to the tumor bed and regional lymph nodes, and chemotherapy may have accounted for the better survival in our node-positive patients.

Entities:  

Mesh:

Year:  1984        PMID: 6749057     DOI: 10.1002/mpo.2950120410

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN: 0098-1532


  2 in total

1.  Localised and unresectable neuroblastoma in infants: excellent outcome with low-dose primary chemotherapy.

Authors:  H Rubie; C Coze; D Plantaz; C Munzer; A S Defachelles; C Bergeron; C Thomas; P Chastagner; D Valteau-Couanet; J Michon; V Mosseri; O Hartmann
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

2.  Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.

Authors:  B De Bernardi; V Mosseri; H Rubie; V Castel; A Foot; R Ladenstein; G Laureys; M Beck-Popovic; A F de Lacerda; A D J Pearson; J De Kraker; P F Ambros; Y de Rycke; M Conte; P Bruzzi; J Michon
Journal:  Br J Cancer       Date:  2008-09-02       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.